Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $841.31 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $248.31 | 3 | $0 (2021) |
| Stryker Corporation | $171.77 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $132.00 | 2 | $0 (2021) |
| Biofrontera Inc. | $121.22 | 1 | $0 (2018) |
| Allergan Inc. | $53.61 | 4 | $0 (2017) |
| GlaxoSmithKline, LLC. | $34.17 | 1 | $0 (2024) |
| Aqua Pharmaceuticals | $21.86 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.21 | 1 | $0 (2017) |
| AbbVie Inc. | $19.67 | 1 | $0 (2021) |
| Galderma Laboratories, L.P. | $18.49 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.17 | 1 | GlaxoSmithKline, LLC. ($34.17) |
| 2022 | $171.77 | 1 | Stryker Corporation ($171.77) |
| 2021 | $188.74 | 5 | Regeneron Healthcare Solutions, Inc. ($132.00) |
| 2019 | $111.61 | 1 | GENZYME CORPORATION ($111.61) |
| 2018 | $239.34 | 2 | Biofrontera Inc. ($121.22) |
| 2017 | $95.68 | 6 | Allergan Inc. ($53.61) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2022 | Stryker Corporation | PRIME SERIES (Device) | Food and Beverage | In-kind items and services | $171.77 | General |
| Category: STRETCHERS | ||||||
| 10/20/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/25/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2021 | Galderma Laboratories, L.P. | ORACEA (Drug), AKLIEF | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ROSACEA | ||||||
| 01/21/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Immunology | ||||||
| 05/02/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $111.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $121.22 | General |
| Category: Dermatology | ||||||
| 05/16/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $118.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2017 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/15/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/12/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/21/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/20/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/14/2017 | Aqua Pharmaceuticals | Acticlate (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 445 | 793 | $71,800 | $39,322 |
| 2020 | 7 | 287 | 593 | $51,002 | $25,005 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 143 | $17,875 | $10,363 | 58.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 49 | 78 | $14,820 | $8,290 | 55.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 64 | 95 | $9,975 | $4,446 | 44.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 74 | 91 | $8,190 | $4,215 | 51.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $7,175 | $3,798 | 52.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 31 | $4,975 | $3,332 | 67.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 28 | 28 | $3,970 | $2,582 | 65.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 50 | 272 | $2,720 | $1,665 | 61.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $2,100 | $631.49 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 107 | 181 | $22,625 | $10,509 | 46.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 36 | 54 | $9,180 | $5,676 | 61.8% |
| 17000 | Destruction of skin growth | Office | 2020 | 48 | 76 | $8,352 | $3,793 | 45.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $3,850 | $1,562 | 40.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 32 | 212 | $2,120 | $1,236 | 58.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 30 | 35 | $3,055 | $1,222 | 40.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 12 | 13 | $1,820 | $1,007 | 55.3% |
About Dr. Eric Smith, M.D
Dr. Eric Smith, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114997277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Smith, M.D has received a total of $841.31 in payments from pharmaceutical and medical device companies, with $34.17 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($841.31).
As a Medicare-enrolled provider, Smith has provided services to 732 Medicare beneficiaries, totaling 1,386 services with total Medicare billing of $64,326. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 01/23/2006
- Last Updated 06/14/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1114997277
Products in Payments
- DUPIXENT (Drug) $229.73
- PRIME SERIES (Device) $171.77
- DUPIXENT (Biological) $150.58
- Ameluz (Drug) $121.22
- VIBERZI (Drug) $42.50
- AREXVY (Drug) $34.17
- Acticlate (Drug) $21.86
- Trintellix (Drug) $20.21
- HUMIRA (Biological) $19.67
- ORACEA (Drug) $18.49
- TEFLARO (Drug) $11.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860